 |
| Meeting Information |
|
| Course Directors |
|
| Scientific Committee |
|
| Association and Affiliations |
|
| TCTAP Live Interviews |
|
| TCTAP Daily Newspaper |
|
 |
|
|
|
|
|
 |
 Learning Objectives |
The participants who will attend the conference can:
• |
Review the latest basic and clinical investigations
to guide how to manage optimally the patients with vascular or structural
heart disease. |
• |
Integrate the newest interventional techniques and devices related
to patient care in the coronary, peripheral and carotid arteries,
and structural heart disease. |
• |
Compare and contrast different approaches to treat the same type
of lesion, and apply an optimal treatment to various patients in their
clinical practice. |
• |
Learn numerous treatment strategies through reviewing diverse challenging
cases submitted from all around the world and discussing with the
world renowned experts. |
• |
Integrate adjunctive pharmacologic management in treating patients
with cardiovascular disease and patients underwent intervention therapies. |
|
| Target Attendees |
• |
Interventional cardiologists |
• |
General cardiologists |
• |
Physicians interested in cardiology and vascular medicine |
• |
Radiologists |
• |
Basic scientists |
• |
Vascular medicine specialists |
• |
Vascular surgeons |
• |
Cardiac surgeons |
• |
Interventional pediatricians |
• |
Nurses and technologists |
• |
Other health care professionals with special interest in the interventional
vascular therapy and medicine |
|
| Program Sponsorship and Support |
ANGIOPLASTY SUMMIT-TCTAP is sponsored by CardioVasucular Research Foundation (CVRF) and Asan Medical Center (Seoul, Korea) and partially funded by educational grants from commercial supporters.
The CardioVascular Research Foundation wishes to extend special appreciation to Clinical Research Center for Ischemic Heart Disease, The Korea Ministry of Health and Welfare in Korea for their continued support to our programs. |
|
|
